| The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells RC Pink, P Samuel, D Massa, DP Caley, SA Brooks, DRF Carter Gynecologic oncology 137 (1), 143-151, 2015 | 213 | 2015 |
| Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells P Samuel, LA Mulcahy, F Furlong, HO McCarthy, SA Brooks, M Fabbri, ... Philosophical Transactions of the Royal Society B: Biological Sciences 373 …, 2018 | 117 | 2018 |
| Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells P Samuel, RC Pink, DP Caley, JMS Currie, SA Brooks, DRF Carter Tumor Biology 37, 2565-2573, 2016 | 85 | 2016 |
| Extracellular vesicles released following heat stress induce bystander effect in unstressed populations F Bewicke-Copley, LA Mulcahy, LA Jacobs, P Samuel, N Akbar, RC Pink, ... Journal of extracellular vesicles 6 (1), 1340746, 2017 | 83 | 2017 |
| Mechanisms of drug resistance in cancer: the role of extracellular vesicles P Samuel, M Fabbri, DRF Carter Proteomics 17 (23-24), 1600375, 2017 | 76 | 2017 |
| miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance P Samuel, RC Pink, SA Brooks, DRF Carter Expert review of anticancer therapy 16 (1), 57-70, 2016 | 45 | 2016 |
| Meta-analysis using a novel database, miRStress, reveals miRNAs that are frequently associated with the radiation and hypoxia stress-responses LA Jacobs, F Bewicke-Copley, MG Poolman, RC Pink, LA Mulcahy, ... PLoS One 8 (11), e80844, 2013 | 35 | 2013 |
| The diagnostic and prognostic potential of microRNAs in epithelial ovarian carcinoma P Samuel, DRF Carter Molecular diagnosis & therapy 21, 59-73, 2017 | 29 | 2017 |
| Detecting ovarian cancer using extracellular vesicles: progress and possibilities E Carollo, B Paris, P Samuel, P Pantazi, TF Bartelli, E Dias-Neto, ... Biochemical Society Transactions 47 (1), 295-304, 2019 | 23 | 2019 |
| Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future RC Pink, EM Beaman, P Samuel, SA Brooks, DRF Carter British Journal of Cancer 126 (3), 323-330, 2022 | 22 | 2022 |
| Confocal microscopy analysis reveals that only a small proportion of extracellular vesicles are successfully labelled with commonly utilised staining methods GE Melling, R Conlon, P Pantazi, ER Dellar, P Samuel, LA Baena-Lopez, ... Scientific Reports 12 (1), 262, 2022 | 14 | 2022 |
| Monitoring the electroactive cargo of extracellular vesicles can differentiate various cancer cell lines CL Miller, M Herrmann, DRF Carter, N Turner, P Samuel, BA Patel Biosensors and Bioelectronics 254, 116224, 2024 | 1 | 2024 |
| The Cytotoxic Effect of Slow Loris (Nycticebus) Venom on Human Cancer M Gardiner, KAI Nekaris, P Samuel Folia Primatologica 88 (2), 171-171, 2017 | 1 | 2017 |
| Genevieve E. Melling1, 2, Ross Conlon3, Paschalia Pantazi1, 4, Elizabeth R. Dellar1, 5 P Samuel, LA Baena‑Lopez, JC Simpson, DRF Carter Scientific Reports 12, 262, 2022 | | 2022 |
| Investigating the role of microRNAs and Extracellular Vesicles in Cisplatin Resistance in Ovarian Cancer P Samuel, S Brooks Oxford Brookes University, 2016 | | 2016 |
| RNAi2015–Ten years of RNAi Oxford F Bewicke-Copley, P Samuel, DRF Carter Journal of Rnai and Gene Silencing: an International Journal of RNA and Gene …, 2015 | | 2015 |
| Author Affiliations P Samuel, M Fabbri, DRF Carter | | |
Dave CarterOxford Brookes UniversityVerified email at brookes.ac.uk
